DPP4 and type 1 diabetes mellitus: Emerging studies have reported evidence that an elevation of serum DPP-4 activity is related to the pancreatic autoimmune process, intestinal proinflammatory alterations, and hepatobiliary injury [21–23] (i.e., DPP-4 may contribute to T1DM pathology).